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Integrated 
Human-Animal 
Disease
Surveillance 
To the Editor: Early identification
of zoonotic disease occurrence
through simultaneous monitoring of
human and animal disease surveil-
lance systems is critical to protect
health in both populations. We
assessed the surveillance and reporting
needs of a small but diverse group of
Michigan veterinarians by examining
their perspective of the current animal
disease reporting system, the system
enhancements desired, and their com-
puter and Internet accessibility. 
Developing systems that link
human and animal disease reporting
systems can help identify and facili-
tate a response to known and emerg-
ing zoonotic diseases. A system that
allows simultaneous electronic cap-
ture and assessment of human and
animal disease reports is being imple-
mented in Michigan. The system will
be based on the Michigan Disease
Surveillance System platform, a Web-
based human disease reporting system
implemented by the Michigan
Department of Community Health
(1,2).
To ensure an integrated system that
meets both human and veterinary
public health needs, we developed a
questionnaire for veterinarians to col-
lect information on the current animal
disease reporting system, system
enhancements that are desired, and
computer and Internet access capabil-
ities (University Human Research
Committee approved). In July 2003, a
total of 112 questionnaires was sent to
a convenience sample of Michigan
veterinarians who represent a variety
of practice types and sizes, participate
in organized veterinary medicine and
academia, and would be motivated to
participate in system development. Of
the 112 questionnaires, 84 (75%) were
completed. Of 79 practices represent-
ed, 19 (24%) treated companion ani-
mals, 15 (19%) treated equids, 4 (5%)
treated food animals (dairy, beef,
small ruminant, poultry, or swine), 32
(41%) treated a variety of animals (no
patient type >75%), 4 (5%) treated
zoo animals, and 5 (6%) veterinarians
were not in clinical practice. 
Of 81 respondents, 75 (93%) indi-
cated that they were aware of the
Michigan reportable animal disease
list. Yet, 37 (47%) of 79 respondents
have reported no cases and 32 (41%)
of 79 have reported 1 to 5 cases annu-
ally. Furthermore, only 19 (25%) of
76 respondents reported that their
clients might have confidentiality
issues that could impede disease
reporting. Therefore, it will be impor-
tant to continue educating veterinari-
ans to ensure that suspected disease
cases are reported as well as con-
firmed cases, which may have been
reported by the laboratory also. 
Positive feedback was received
regarding the current animal disease
reporting system. Respondents evalu-
ated the availability of a published list
of reportable diseases (68 [89%] of
76) and the availability and quality of
laboratory testing and disease confir-
mation (57 [75%] of 76) as Strongly
Like/Like (Scale = Strongly Dislike,
Dislike, No Opinion, Like, Strongly
Like). However, case submission
feedback may need to be assessed as
only 34 (45%) of 76 respondents eval-
uated this service as Strongly
Like/Like and 13 (17%) of 76 evalu-
ated it as Strongly Dislike/Dislike.
Of 73 respondents, 68 (93%)
reported that routinely published ani-
mal disease surveillance data would
be beneficial for themselves or their
clients. Of 55 respondents, 24 (44%)
indicated that these data would be
used to increase disease awareness
and 23 (42%) indicated the data
would be used for risk assessment and
prevention planning. Outbreak alert
information, easy access to regulatory
requirements, and animal disease
information were also desired.
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Virtually all practices had a com-
puter (79 [99%] of 80), Internet
access (70 [88%] of 80), and email
(53 [75%] of 71). Most (68 [91%] of
75) were comfortable using a Web-
based application to submit case
reports. However, because Internet
access and email may not be univer-
sal, multiple modes of communication
must be utilized. Furthermore, of 81
respondents, 29 (36%) indicated lack
of time, and 24 (30%) indicated lack
of staff as a barrier to online reporting.
Therefore, the reporting system
should be efficient.
Rabies, bovine tuberculosis, and
West Nile virus, all zoonotic diseases,
were listed by >50% of the 79 respon-
dents as 1 of the 6 diseases they felt
were most important in Michigan.
Simultaneous tracking of human and
animal diseases was considered useful
by 32 (84%) of 38 respondents
because animals are sentinels of
human (zoonotic) disease and by 7
(18%) respondents because of the
threat of agroterrorism. In general,
respondents are aware of the impor-
tance of animal disease reporting to
public health.
In Michigan, the human and ani-
mal disease reporting systems are
similarly structured, although there is
no local level animal health agency
(Figure). These similarities can pro-
vide the basis for a system that is
functionally appropriate to track dis-
eases in humans and multiple animal
species and meet multiple agency sur-
veillance objectives.
Overall, this group of Michigan
veterinarians considers developing a
Web-based disease reporting system
as useful as long as the following
issues are addressed: 1) quality case
report feedback; 2) access to correct
and coordinated human and animal
disease information; and 3) computer
system reliability and efficiency.
Based on the results of this study, the
second phase of this project, construc-
tion of the animal disease surveillance
portion of Michigan’s reporting sys-
tem, will be implemented with contin-
ued input from local, state, and feder-
al stakeholders.
Funding from the Michigan
Department of Community Health sup-
ported this study.
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VanB-VanC1
Enterococcus 
gallinarum, Italy 
To the Editor:We report detecting
a vanB determinant in Enterococcus
gallinarum in poultry in Italy. High-
level vanA-mediated glycopeptide
resistance has been described for E.
gallinarum and E. casseliflavus (1–4),
and vanB-mediated vancomycin
resistance has been frequently
described for E. faecalis and E. faeci-
um. However, vanB-mediated resist-
ance in isolates of E. gallinarum has
been described only in sporadic noso-
comial cases of infection or coloniza-
tion (5,6).
In January 2005, a study of con-
tamination by foodborne organisms in
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Figure. Comparison of Michigan human and animal disease reporting system structures.
LHJ, Local Health Jurisdiction; MDCH, Michigan Department of Community Health; CDC,
Centers for Disease Control and Prevention; WHO, World Health Organization; MDA,
Michigan Department of Agriculture; USDA, US Department of Agriculture; Animal Plant
Health Inspection Service, Veterinary Services; OIE, Office International Epizooties.